Portal Hypertension Using Magnetic Resonance Elastography
NCT ID: NCT05749198
Last Updated: 2023-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
47 participants
OBSERVATIONAL
2018-01-02
2023-01-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multiparametric Cardio-hepatic MRI in Patients With Noncirrhotic Portal Hypertension
NCT05041452
3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension
NCT06205992
Assessment of Portal Hypertension With Multiparametric MRI
NCT03436550
Diagnosis of Pulmonary Hypertension Using Cardiac Magnetic Resonance Images
NCT02790918
A Study to Evaluate Renal Fibrosis Using MRI Techniques
NCT04508049
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRE
MRE was performed using a 3T system (Magnetom Skyra; Siemens, Erlangen, Germany) equipped with a combination of a 30-channel body and a 32-channel spine matrix coil.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* requiring prophylactic treatment of esophageal varices
Exclusion Criteria
* refractory ascites who regularly underwent large-volume paracentesis
* the use of selective beta-blocker or carvedilol therapy for at least 4 weeks
* undergoing liver transplantation
* contraindication with magnetic resonance imaging
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yonsei University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Moon Young Kim
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wonju Severance Christian Hospital
Wŏnju, Gangwon-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR317132
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.